John Hopkins Webinar on transplant recipients and vaccines

Posted by bosco17 @bosco17, Mar 24, 2021

They said after first shot 17 out of 800+patients had only a minimal antibody reaction .Also being on mycophelonate reduces effect of vaccines.WHATS GOING ON ??????

Interested in more discussions like this? Go to the Transplants Support Group.

athenalee | @athenalee | Mar 26, 2021

In reply to @estrada53 "Hi Rosemary. I don't know if the recorded webinar is posted yet. I'm attaching the news..." + (show)

It’s posted, but you need a passcode to access it. https://transplantvaccine.org/study-results-and-webinars/

estrada53 | @estrada53 | Mar 26, 2021

In reply to @athenalee "It’s posted, but you need a passcode to access it. https://transplantvaccine.org/study-results-and-webinars/" + (show)

@athenalee Are you able to open this link?
https://jamanetwork.com/journals/jama/fullarticle/2777685

athenalee | @athenalee | Mar 26, 2021

In reply to @estrada53 "@athenalee Are you able to open this link? https://jamanetwork.com/journals/jama/fullarticle/2777685" + (show)

Yes. I’ve read it. And, I saw the webinar. Thanks.

estrada53 | @estrada53 | Mar 26, 2021

In reply to @athenalee "Yes. I’ve read it. And, I saw the webinar. Thanks." + (show)

Oh. I thought you meant you didn't have a pass code to access the article. :/

athenalee | @athenalee | Mar 26, 2021

In reply to @estrada53 "Oh. I thought you meant you didn't have a pass code to access the article. :/" + (show)

No. I’m sorry. You had asked about the recording....which I had found earlier, but didn’t post it since it required a passcode. And, I couldn’t find any reference as to how to get said passcode.🤔

Rosemary, Volunteer Mentor | @rosemarya | Mar 26, 2021

In reply to @snorris "Interview with the Doc leading the study. https://www.medpagetoday.com/infectiousdisease/covid19/91775" + (show)

@snorris, Thank you for the link to the interview. It is very helpful and has given me the information in clear understandable terms.

Welcome to Connect. I can see that you have ben a member for a while, and that this is your first post. I am glad that you chose to jump in with this information.
Are you a transplant recipient?

estrada53 | @estrada53 | Mar 26, 2021

In reply to @athenalee "No. I’m sorry. You had asked about the recording....which I had found earlier, but didn’t post..." + (show)

Got it! Thanks!

snorris | @snorris | Mar 27, 2021

In reply to @rosemarya "@snorris, Thank you for the link to the interview. It is very helpful and has given..." + (show)

Hi Rosemary. My husband received his new liver at Mayo Rochester in October 2018. It’s been a long road, 33 days in hospital post transplant, he’s doing well now, and we have found this forum very helpful.

luckonetj | @luckonetj | Mar 31, 2021

https://www.dovepress.com/coronavirus-disease-2019-covid-19-and-transplantation-pharmacotherapeu-peer-reviewed-fulltext-article-TCRM
This link is to a medical journal that deals with Covid 19. Transplants, and treatments.

luckonetj | @luckonetj | Mar 31, 2021

In reply to @rosemarya "@snorris, Thank you for the link to the interview. It is very helpful and has given..." + (show)

Evidently Tacrolimus is a prophylactic for Covid 19 in preventing sever infection.
Tacrolimus is immunosuppressive by inhibiting calcineurin, and suppressing the early phase of T-cell activation, and the expression of many cytokines (IL-2, IL-4, TNF-α and IFN-γ) that are needed in the activation of the cellular immune response, possibly preventing a cytokine storm as observed in severe COVID-19.Jun 27, 2020
https://www.ncbi.nlm.nih.gov › pmc
Calcineurin inhibitors revisited: A new paradigm for COVID-19? - NCBI - NIH